This imbalance between demand for investigation at f‐Hb ≥ 10 μg/g and supply of colonoscopy or CT‐colonography means that investigations will be delayed for some people at higher risk of CRC while many normal investigations are being performed. This evidence concerns the gene GSTM1 and colorectal carcinoma.